Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 461 clinical trials
Featured trial
A Double-Blind, Placebo-Controlled Study of Cariprazine as an Adjunct to Antidepressants in the Treatment of Patients With Major Depressive Disorder Who Have Had an Indadequate Response to Antidepressants Alone

A study to evaluate the efficacy, safety, and tolerability of cariprazine compared with placebo as an adjunctive treatment to ongoing antidepressant therapy in patients with major depressive

antidepressants
depressive disorder
antidepressant therapy
  • 120 views
  • 23 Nov, 2020
  • 1 location
Featured trial
Depressed?

Depressed?

  • 903 views
  • 08 Nov, 2020
  • 1 location
Featured trial
Study Seeking Patients with Depression

Study Seeking Patients with Depression

  • 612 views
  • 25 Mar, 2021
  • 1 location
Featured trial
Adolescent Non-Drug Depression Study: A randomized, sham-controlled trial Evaluating the Safety and Effectiveness of ---- device in depressed adolescents

Adolescent Non-Drug Depression Study: A randomized, sham-controlled trial Evaluating the Safety and Effectiveness of ---- device in depressed adolescents

  • 361 views
  • 23 Nov, 2020
  • 1 location
Featured trial
A Placebo-controlled, Double-blind, Parallel-group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Study to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease

A Placebo-controlled, Double-blind, Parallel-group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Study to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease

  • 258 views
  • 08 Dec, 2020
  • 1 location
Featured trial
Alzheimer’s Disease Research Center (ADRC) Longitudinal Study

This study is looking for people with mild cognitive impairment, young-onset Alzheimer’s, frontotemporal dementia, or Lewy body dementia. The study is also looking for cognitively-normal people over the age of 65, as a comparison. The study will follow the progression of various dementias to help with early detection, accurate diagnosis, …

dementia
depression
cancer
cognitive impairment
mild cognitive impairment
  • 215 views
  • 25 Jan, 2022
  • 1 location
Featured trial
A 26-Week, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Daily Administration of AC-1204 in Participants With Mild to Moderate Alzheimer's Disease (AD) With an Optional 26-Week Open Label Extension

A 26-Week, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Daily Administration of AC-1204 in Participants With Mild to Moderate Alzheimer's Disease (AD) With an Optional 26-Week Open Label Extension

  • 171 views
  • 08 Dec, 2020
  • 1 location
Study of Efficacy and Safety of MIJ821 in Addition to Comprehensive Standard of Care on the Rapid Reduction of Symptoms of Major Depressive Disorder in Subjects Who Have Suicidal Ideation With Intent

Study of efficacy and safety of MIJ821 in addition to comprehensive standard of care on the rapid reduction of symptoms of Major Depressive Disorder (MDD) in subjects who have suicidal ideation

  • 75 views
  • 29 Jul, 2022
  • 36 locations
An Implementation Study of Suicide Risk Management Among Discharged Psychiatric Patients

suicide intervention strategy. The study will recruit patients with psychotic symptoms and with major depressive disorder discharged from Shenzhen Kangning Hospital (SKH) in a Sequential Multiple

depressive disorder
  • 0 views
  • 27 Apr, 2022
  • 1 location
Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression

The study aims to investigate the safety and efficacy of oral psilocybin administered under supportive conditions in treatment-resistant major depression (TRD). The study is a bi-centric

  • 0 views
  • 08 Aug, 2021
  • 2 locations